11 COVID-19 therapies you need to know

The pharmaceutical industry launched a herculean effort to battle the COVID-19 pandemic early in 2020, developing an array of vaccines and other therapeutics while also identifying existing drugs suitable for treating patients sick with severe coronavirus infections.

FDA recently granted emergency authorization to two SARS-CoV-2 vaccines and several other treatments.

Here are 11 of the most high-profile COVID-19 therapies to date. Some have already received emergency use authorization from FDA, while others will likely receive EUAs in 2021.

Next>>

---

Filed Under: clinical trials, Drug Discovery, Infectious Disease
Tagged With: AstraZeneca plc, BioNTech, clinical trials, coronavirus, covid-19, COVID-19 vaccine, COVID-19 vaccine trial, Donald Trump, Eli Lilly & Co., FDA, GlaxoSmithKline, GSK, Janssen Pharmaceuticals, Johnson & Johnson, Merck, Moderna, National Institutes of Health, Pfizer, Regeneron
 

---